<!--
<hr>
<div class="" id="resultsfooter">
<div class="col-sm-6" >
<b>AFB Smear</b><br>
Qualitative AFB smearAuramine-Rhodamine stain at 200 X<br>
No AFB seen = 0 AFB per 30 fields. <br>
Actual No. = 1-29 AFB per 30 fields 
<br>
1+ = 30-299 AFB per 30 fields<br>
2+ = 10-100 AFB per field<br>
3+ = > 100 AFB per field<br>
Ziehl Neelsen Ziehl Neelsen stain at 100 X<br>
AFB Present or No AFB Seen<br>
Quantitative AFB smearAuramine-Rhodamine stain at 400 X log AFB/mL sputum<br>
<b>Cultures</b><br>
LJ or 7H10 selective and non-selective media Qualitative: Quantitative:
Growth or No growth after Eight weeksLog CFU(colony forming units) / mL Semi-quantitative:
No growth after six weeks or:  
None = No growth
1-9 colonies = actual number
10 - 100 colonies = 1+>100-200 colonies = 2+
>200 colonies (Confluent) = 3+

</div>
<div class="col-sm-6" >
Susceptibility Testing MGIT 960
Drug susceptibility testing of MTB, on the MGIT 960 System, is based on the modified proportion method. If 1% or more of a test population of tubercle bacilli are resistant to a drug, the culture is considered “resistant”.
If not, "sensitive."
Critical drug concentrations compared:
<table>
<tr>
<th>Drug (ug/mL)</th><th>MGIT</th><th>LJ</th><th>7H10</th></tr>
<tr>
<td>Streptomycin</td><td>1.0</td><td>4.0</td><td>2.0</td></tr>
<tr>
<td>Isoniazid</td><td>0.1</td><td>0.2</td><td>0.2</td></tr>
<tr>
<td>Rifampin</td>1.0<td></td>40.0<td>1.0</td></tr>
<td>Ethambutol</td>5.0<td></td>2.0<td>5.0</td></tr>
<td>
Pyrazinamide</td>100.0<td></td><td></td></tr> 
</table><br>
 <b>Blood Agar Culture</b><br>
No growth = Not contaminated with organisms able to grow on blood agar
Contaminated = Growth of organisms other than mycobacteria
MOTT = Contaminated with rapid growing mycobacteria, not MTB
Identification TB Ag MPT 64
Identification methods differentiate M. tuberculosis (MTB) complex (M. tuberculosis, M. bovis, M. africanum, M. microti) from Mycobacteria Other Than Tuberculosis (MOTT). Positve = MTB; Negative = MOTT
</div>
</div>-->